Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report

Abstract Background Tuberculosis (TB) reactivation has been increasingly identified following immune checkpoint inhibitor (ICI) therapy for cancer patients. However there has been no report on TB reactivation in the gastrointestinal tract. In the report, we describe a patient who developed TB ileiti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kin-Sang Lau, Ben Man-Fei Cheung, Ka-On Lam, Sum-Yin Chan, Ka-Ming Lam, Chun-Fai Yeung, Ivan Fan-Ngai Hung, Dora Lai-Wan Kwong, Chi-Chung Tong, To-Wai Leung, Mai-Yee Luk, Anne Wing-Mui Lee, Kwok-Keung Yuen, Victor Ho-Fun Lee
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Nasopharyngeal carcinoma Immune checkpoint inhibitors Tuberculosis reactivation IGRA Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/2540bea4e0744c0db3e2bb0711216fb7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report

Ejemplares similares